tiprankstipranks
China Pharma Holdings (CPHI)
:CPHI
US Market

China Pharma Holdings (CPHI) Income Statement

Compare
267 Followers

China Pharma Holdings Income Statement

Last quarter (Q3 2024), China Pharma Holdings's total revenue was $1.10M, a decrease of -39.00% from the same quarter last year. In Q3, China Pharma Holdings's net income was $-1.12M. See China Pharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 7.01M$ 8.10M$ 9.64M$ 10.87M$ 10.92M
Gross Profit
$ -281.08K$ -493.92K$ 349.27K$ 1.95M$ 1.48M
Operating Expenses
$ 2.47M$ 3.15M$ 3.46M$ 4.42M$ 4.87M
Depreciation and Amortization
$ 2.75M$ 2.70M$ 3.09M$ 2.68M$ 2.93M
EBITDA
$ 8.44K$ -837.69K$ 230.34K$ 106.85K$ -17.45M
Operating Income
$ -2.75M$ -3.55M$ -3.12M$ -2.46M$ -3.39M
Other Income/Expenses
$ -327.00K$ -423.86K$ -538.97K$ -288.48K$ -17.31M
Pretax Income
$ -3.08M$ -3.97M$ -3.40M$ -2.87M$ -20.70M
Net Income
$ -3.08M$ -10.22M$ -3.94M$ -3.16M$ -21.02M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.91$ -1.94$ -0.85$ -0.72$ -4.82
Diluted EPS
$ -0.91$ -1.94$ -0.85$ -0.72$ -4.82
Weighted Average Shares Outstanding
3.38M 5.26M 4.61M 4.36M 4.36M
Weighted Average Shares Outstanding (Diluted)
3.38M 5.26M 4.61M 4.36M 4.36M
Currency in USD

China Pharma Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis